Matrix Trust Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,023
Closed -$1.57M 75
2023
Q3
$1.57M Buy
20,023
+226
+1% +$18.9K 0.41% 32
2023
Q2
$1.74M Buy
19,797
+1,154
+6% +$99.3K 0.45% 29
2023
Q1
$1.5M Buy
18,643
+7,566
+68% +$617K 0.4% 30
2022
Q4
$861K Buy
11,077
+550
+5% +$44.6K 0.22% 46
2022
Q3
$850K Buy
10,527
+3,082
+41% +$277K 0.24% 35
2022
Q2
$668K Buy
7,445
+5,267
+242% +$534K 0.18% 37
2022
Q1
$242K Buy
+2,178
New +$230K 0.06% 40

Other funds holding MDT

Matrix Trust Company's MDT Position: Q4 2023 in Review

Matrix Trust Company sold out of Medtronic (MDT) in Q4 2023, closing a stake of 20,023 shares — an estimated $1.57M sold.

Matrix Trust Company first reported a position in MDT in Q1 2022 and held it in 7 quarters. The position peaked at $1.74M in Q2 2023. 2,075 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Matrix Trust Company reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Matrix Trust Company sold 20,023 Medtronic shares in Q4 2023, an estimated $1.57M.
  • Matrix Trust Company first reported a position in Medtronic in Q1 2022 and held it in 7 quarters.
  • Matrix Trust Company's Medtronic position peaked at $1.74M in Q2 2023.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Matrix Trust Company's 13F filing for Q4 2023, filed 5 Feb 2024.